FDA Inspection
Boehringer Ingelheim RCV GmbH & Co KGBoehringer Ingelheim RCV GmbH & Co KG – FDA Inspection, Dec 5, 2023
Record Details
This FDA Inspection record concerns Boehringer Ingelheim RCV GmbH & Co KG, with an inspection on December 5, 2023, issued by the Office of Inspections and Investigations.
- Inspection Date
- December 5, 2023
View Company Profile
ID · 58b1a87d-a90e-4ba5-b7e5-ec998156c23b
Inspection Facts
- Inspection number
- 1226783
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Boehringer Ingelheim RCV GmbH & Co KG
13| Date | Classification | Office | Project area |
|---|---|---|---|
| November 12, 2024 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| November 16, 2023 | Not classified | Office of Inspections and Investigations | |
| March 2, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 16, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| January 28, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Boehringer Ingelheim RCV GmbH & Co KG
- FDA Inspection 1258048 - 2024-11-12
- FDA Inspection 1223893 - 2023-11-16
- FDA Inspection 1210971 - 2023-03-02
- FDA Inspection 1182096 - 2022-09-16
- FDA Inspection 1170761 - 2021-01-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.